• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

NovoLog insulin aspart (rDNA origin) injection

Audience: Pharmacists and other healthcare professionals

[Posted 09/14/2005] Novo Nordisk Incorporated and FDA notified pharmacists of an initiative implemented to help prevent dispensing errors. To facilitate the dispensing of the correct product, color branded labeling has been introduced for NovoLog Mix 70/30, a premixed insulin analog, and NovoLog, a rapid-acting insulin analog. The previous box for NovoLog Mix 70/30 was white with a blue band. The current packaging for NovoLog Mix 70/30 is very similar and remains white with a blue band. The packaging for NovoLog previously was also white with a blue band. The current packaging is now white with an orange band. It is important that all pharmacists carefully distinguish insulin formulations by name and NDC number when dispensing.

[August 26, 2005 - Letter - Novo Nordisk Inc.]